NICOLE FITTS: Open Payments
NPI 1356843684 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,366 in 62 payments from 23 companies in 2025. Trend: 2023 $681 · 2024 $690 · 2025 $1,366
Food & beverage: $1,323Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $215 |
| Regeneron Healthcare Solutions, Inc. | 7 | $192 |
| Merck Sharp & Dohme LLC | 4 | $101 |
| GlaxoSmithKline, LLC. | 4 | $90 |
| JAZZ PHARMACEUTICALS INC. | 3 | $86 |
| Viatris Specialty LLC | 5 | $84 |
| GENZYME CORPORATION | 2 | $68 |
| PFIZER INC. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Insmed, Inc. | 2 | $48 |
Products named: DUPIXENT, FASENRA, NUCALA, XYWAV, YUPELRI, ZERBAXA, TEZSPIRE, PREVNAR 20.
Industry payments across MO — which companies pay providers there.
